TIP-15. Trial in progress: phase IB study of concurrent Azeliragon, a RAGE inhibitor, with craniospinal irradiation in patients with leptomeningeal metastases
K.M. Banson(NYU Langone Health), Jonathan T. Yang(New York University), J Ricardo McFaline-Figueroa(NYU Langone Health), Benjamin T. Cooper(New York University), Erik P. Sulman(NYU Langone Health), Joshua S. Silverman(NYU Langone Health), Maria del Pilar Guillermo Prieto Eibl(NYU Langone Health), Alexandra M Miller(Cornell University), Judith D. Goldberg(New York University), Stephen Marcus(Fort Worth Library), Marissa Barbaro(NYU Langone Health)
Cited by 0
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
|Cell|2016|277
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
|Nature Biotechnology|2005|238